Neochem Bio Solutions
NEOCHEM NSE
Neochem Bio Solutions
ChemicalsNSE: NEOCHEM Specialty Chemicals
Key Fundamentals
SMESpecialty ChemicalsChemicalsMarket Cap
₹171 Cr
Volatility
Moderate
P/E Ratio
0
EBITDA
₹15.10 Cr
Return on Equity
39.24%
Debt to Equity
0.23
Book Value
₹46.05
52W High
₹121
52W Low
₹63
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 161 days.
- Working capital days have increased from 77.8 days to 164 days
Growth Rate
Revenue Growth
39.03% higher than
3Y
Net Income Growth
333% higher than
3Y
Cash Flow Change
32.14% lower than
3Y
ROE
161%
ROCE
118%
EBITDA Margin (Avg.)
58.55%
Quarterly Results
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 47 | 65 |
| Expenses | 39 | 54 |
| Operating Profit | 8 | 11 |
| OPM % | 17% | 17% |
| Other Income | 2 | 1 |
| Interest | 2 | 2 |
| Depreciation | 1 | 1 |
| PBT | 7 | 10 |
| Tax % | 24% | 30% |
| Net Profit | 6 | 7 |
| EPS in Rs | 8.31 | 4.01 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 49 | 48 | 61 | 84 | 111 |
| Expenses | 45 | 44 | 55 | 71 | 91 |
| Operating Profit | 4 | 4 | 6 | 13 | 20 |
| OPM % | 7% | 9% | 10% | 15% | 18% |
| Other Income | 0 | 1 | 1 | 2 | 2 |
| Interest | 1 | 2 | 3 | 4 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| PBT | 1 | 2 | 3 | 10 | 17 |
| Tax % | 25% | 28% | 31% | 25% | 30% |
| Net Profit | 1 | 1 | 2 | 7 | 12 |
| EPS in Rs | 3.23 | 2.1 | 2.89 | 11.15 | 7.03 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 7 | 7 | 17 |
| Reserves | 1 | 3 | 6 | 13 | 62 |
| Borrowings | 23 | 26 | 33 | 36 | 18 |
| Other Liabilities | 19 | 16 | 18 | 24 | 20 |
| Total Liabilities | 46 | 51 | 63 | 79 | 117 |
| Fixed Assets | 12 | 15 | 19 | 19 | 20 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 |
| Other Assets | 34 | 36 | 45 | 60 | 91 |
| Total Assets | 46 | 51 | 63 | 79 | 117 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -1 | -1 | -1 | 2 | -17 |
| Investing | -3 | -3 | 12 | -1 | -9 |
| Financing | 4 | 4 | -11 | -1 | 26 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -4 | -4 | 11 | 1 | -19 |
| CFO/OP | -36 | -23 | -10 | 23 | -70 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 102 | 107 | 100 | 110 | 161 |
| Inventory Days | 141 | 173 | 172 | 157 | 143 |
| Days Payable | 186 | 155 | 142 | 111 | 56 |
| Cash Conversion Cycle | 58 | 125 | 131 | 156 | 247 |
| Working Capital Days | 17 | 19 | 30 | 39 | 164 |
| ROCE % | — | 12% | 14% | 26% | 28% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Neochem Bio Solutions insights
46 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Updates
10 Sep - Promoter Swapnil Rameshbhai Makati bought 7,200 shares on 09.09.2026, raising holding to 54.74%. 10 Sep - Promoter Swapnil Rameshbhai Makati bought 7,200 shares on 09.09.2026, raising holding to 54.74%.
2
Change in Management
29 Aug - Neochem Bio Solutions appointed Siddharth Raj as Business Head (Textiles) Corporate Accounts, effective August 29, 2026. 29 Aug - Neochem Bio Solutions appointed Siddharth Raj as Business Head (Textiles) Corporate Accounts, effective August 29, 2026.
3
Copy of Newspaper Publication
27 Aug - Newspaper publication of 9th AGM notice; remote e-voting starts September 18, 2026, cut-off September 14. 27 Aug - Newspaper publication of 9th AGM notice; remote e-voting starts September 18, 2026, cut-off September 14.
4
Shareholders meeting
26 Aug - Neochem schedules 9th AGM on 21 Sep 2026 and dispatches FY26 annual report electronically. 26 Aug - Neochem schedules 9th AGM on 21 Sep 2026 and dispatches FY26 annual report electronically.
5
General Updates
26 Aug - Neochem dispatched FY2025-26 annual report, scheduled 9th AGM on 21 September 2026. 26 Aug - Neochem dispatched FY2025-26 annual report, scheduled 9th AGM on 21 September 2026.
Frequently Asked Questions about Neochem Bio Solutions
What does Neochem Bio Solutions Ltd do?
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]
Where is Neochem Bio Solutions Ltd (NEOCHEM) listed?
Neochem Bio Solutions Ltd trades as NEOCHEM on the NSE.
Which sector does Neochem Bio Solutions Ltd belong to?
Neochem Bio Solutions Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Neochem Bio Solutions Ltd?
Neochem Bio Solutions Ltd has a market capitalisation of ₹171.21 Cr, which places it in the Small Cap band.
What is the PE ratio of Neochem Bio Solutions Ltd?
Neochem Bio Solutions Ltd trades at a PE ratio of 0.00, against a book value of ₹46.05 per share.
What is the 52-week high and low of Neochem Bio Solutions Ltd?
Over the last 52 weeks Neochem Bio Solutions Ltd has traded between ₹63 and ₹121.
What is the Return on Equity (ROE) of Neochem Bio Solutions Ltd?
Neochem Bio Solutions Ltd reported a return on equity of 39.24%. Its debt-to-equity ratio is 0.23.
Company Information
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NEOCHEM.md for Neochem Bio Solutions Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.